Antiretroviral Resistance in Clinical Practice.
Geretti AM, editor.
London: Mediscript; 2006.
Top results in this bookTable of Contents
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Darunavir/Cobicistat (Prezcobix) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jul.
Clinical Review Report: Emtricitabine/tenofovir alafenamide fumarate (Descovy) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug.
Clinical Review Report: Dolutegravir/Lamivudine (Dovato): (ViiV Healthcare ULC): Indication: As a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents 12 years of age and older and weighing at least 40 kg [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Oct.
Clinical Review Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/FTC/TAF) (Biktarvy): (Gilead Sciences Canada, Inc.): Indication: A complete regimen for the treatment of HIV-1 infection in adults with no known substitution associated with resistance to the individual components of Biktarvy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Clinical Review Report: Dolutegravir/Rilpivirine (Juluca): (ViiV Healthcare): Indication: As a complete regimen to replace the current antiretroviral regimen for the treatment of HIV-1 infection in adults who are virologically stable and suppressed (HIV-1 RNA less than 50 copies per mL) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jun.
Review of the HIVNET 012 Perinatal HIV Prevention Study.
Institute of Medicine (US) Committee on Reviewing the HIVNET 012 Perinatal HIV Prevention Study.
Washington (DC): National Academies Press (US); 2005.
Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy.
Geneva: World Health Organization; 2017.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2021 Jan-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Common Drug Review New Combination Product: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination (Delstrigo): Merck Canada Inc. Indication: A complete regimen for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults without past or present evidence of viral resistance to doravirine, lamivudine, or tenofovir [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun.
Endotext [Internet].
Feingold KR, Anawalt B, Boyce A, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Pharmacoeconomic Review Report: Dolutegravir/Lamivudine (Dovato): (ViiV Healthcare ULC): Indication: As a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents 12 years of age and older and weighing at least 40 kg [Internet].
Drugs and Lactation Database (LactMed) [Internet].
Bethesda (MD): National Library of Medicine (US); 2006-.
Guidance on Pre-Exposure Oral Prophylaxis (PrEP) for Serodiscordant Couples, Men and Transgender Women Who Have Sex with Men at High Risk of HIV: Recommendations for Use in the Context of Demonstration Projects.
Geneva: World Health Organization; 2012 Jul.
Pharmacoeconomic Review Report: Dolutegravir/Rilpivirine (Juluca): (ViiV Healthcare ULC): Indication: As a complete regimen to replace the current antiretroviral regimen for the treatment of HIV-1 infection in adults who are virologically stable and suppressed (HIV-1 RNA < 50 copies/mL) [Internet].
Pharmacoeconomic Review Report: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/FTC/TAF) (Biktarvy): (Gilead Sciences Canada, Inc.): Indication: A complete regimen for the treatment of HIV-1 infection in adults with no known substitution associated with resistance the individual components of Biktarvy [Internet].
Pharmacoeconomic Review Report: dolutegravir (Tivicay) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Aug.
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis.
Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors.
Cambridge: Cambridge University Press; 2007.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on